Leukemia & Lymphoma
Volume 63, 2022 - Issue 6
Open access
4,931
Views
4
CrossRef citations to date
0
Altmetric
Original Articles
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
Christopher M. Meléna Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden;b Medical Unit Hematology, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]
View further author information
, View further author information
Magali Merrienc Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, SwedenView further author information
, Agata M. Wasikc Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, SwedenView further author information
, Georgios Panagiotidisd Department of Laboratory Medicine, Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden;e Unit of Clinical Pharmacology, University Hospital, Stockholm, SwedenView further author information
, Olof Beckd Department of Laboratory Medicine, Division of Pharmacology, Karolinska Institutet, Stockholm, Sweden;e Unit of Clinical Pharmacology, University Hospital, Stockholm, Sweden
https://orcid.org/0000-0002-3546-8872View further author information
Kristina Sonnevia Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden;b Medical Unit Hematology, Karolinska University Hospital, Stockholm, SwedenView further author information
, Henna-Riikka Junléna Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden;b Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden
https://orcid.org/0000-0003-4749-0601View further author information
Birger Christenssonc Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden;f Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, SwedenView further author information
, Birgitta Sanderc Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden;f Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, SwedenView further author information
& Björn Engelbrekt Wahlina Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden;b Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden
https://orcid.org/0000-0003-3566-8847View further author information
Pages 1387-1397
|
Received 02 Jul 2021, Accepted 09 Dec 2021, Published online: 17 Jan 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.